Anna Nowak

Anna Nowak at the University of Western Australia is a leading mesothelioma researcher in Australia, a country with high mesothelioma incidence due to asbestos mining history. She contributed to the CHECKMATE-743 trial and has been central to Australian mesothelioma clinical research. Her work spans clinical trial leadership, translational biology, and advocacy for mesothelioma patients and research funding. She has contributed to understanding prognostic factors and palliative care approaches in mesothelioma. Her leadership in international mesothelioma research networks has elevated the field globally.